Carlota Costa

3.6k total citations
41 papers, 1.6k citations indexed

About

Carlota Costa is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Carlota Costa has authored 41 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 21 papers in Pulmonary and Respiratory Medicine and 19 papers in Oncology. Recurrent topics in Carlota Costa's work include Lung Cancer Treatments and Mutations (19 papers), Cancer Genomics and Diagnostics (17 papers) and Cancer therapeutics and mechanisms (8 papers). Carlota Costa is often cited by papers focused on Lung Cancer Treatments and Mutations (19 papers), Cancer Genomics and Diagnostics (17 papers) and Cancer therapeutics and mechanisms (8 papers). Carlota Costa collaborates with scholars based in Spain, United States and Italy. Carlota Costa's co-authors include Rafael Rosell, Ana Giménez‐Capitán, Miquel Tarón, Niki Karachaliou, Miguel Ángel Molina‐Vila, Trever G. Bivona, Clara Mayo, Vincent A. Miller, Kenneth Chang and Philicia Moonsamy and has published in prestigious journals such as Nature, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Carlota Costa

38 papers receiving 1.5k citations

Peers

Countries citing papers authored by Carlota Costa

Since Specialization

Citations

This map shows the geographic impact of Carlota Costa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carlota Costa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carlota Costa more than expected).

Fields of papers citing papers by Carlota Costa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carlota Costa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carlota Costa. The network helps show where Carlota Costa may publish in the future.

Co-authorship network of co-authors of Carlota Costa

This figure shows the co-authorship network connecting the top 25 collaborators of Carlota Costa. A scholar is included among the top collaborators of Carlota Costa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carlota Costa. Carlota Costa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Current advances in cancer immunohistochemistry: a new perspective for the Ki-67 biomarker 2025 ·ecancermedicalscience ·Teresa Santos, (unknown), Karin Soares Cunha, Carlota Costa, (unknown), Helena Castro, (unknown)	0
2	Combinatory effect of BRCA1 and HERC2 expression on outcome in advanced non-small-cell lung cancer 2016 ·BMC Cancer ·Laura Bonanno, Carlota Costa, Margarita Majem, (unknown), Ignacio Rodríguez, Ana Giménez‐Capitán, (unknown), A. Vergnenègre, Bartomeu Massutí, Adolfo Favaretto, Massimo Rugge, Cinta Pallarés, Miquel Tarón, Rafael Rosell	22
3	The Impact of EGFR T790M Mutations and BIM mRNA Expression on Outcome in Patients with EGFR -Mutant NSCLC Treated with Erlotinib or Chemotherapy in the Randomized Phase III EURTAC Trial 2014 ·Clinical Cancer Research ·Carlota Costa, Miguel Angel Molina, Ana Drozdowskyj, Ana Giménez‐Capitán, Jordi Bertrán-Alamillo, Niki Karachaliou, Radj Gervais, Bartomeu Massutí, Jia Wei, Teresa Morán, Margarita Majem, Enriqueta Felip, Enric Carcereny, Rosario García‐Campelo, Santiago Viteri, Miquel Tarón, Mayumi Ono, Petros Giannikopoulos, Trever G. Bivona, Rafael Rosell	180
4	Plasma mRNA expression levels of BRCA1 and TS as potential predictive biomarkers for chemotherapy in gastric cancer 2014 ·Journal of Translational Medicine ·Jie Shen, Jia Wei, Wenxian Guan, Hao Wang, Yitao Ding, Xiaoping Qian, Lixia Yu, Zhengyun Zou, Li Xie, Carlota Costa, Trever G. Bivona, Rafael Rosell, Baorui Liu	17
5	Differential effect of MMSET mRNA levels on survival to first-line FOLFOX and second-line docetaxel in gastric cancer 2014 ·British Journal of Cancer ·Jia Wei, Carlota Costa, Jie Shen, Lixia Yu, José Javier Sánchez, Xiaoping Qian, Xuan Sun, Zhengyun Zou, Ana Giménez‐Capitán, Guofeng Yue, Wenxian Guan, Rafael Rosell, (unknown)	7
6	Erlotinib Resistance in Lung Cancer Cells Mediated by Integrin β1/Src/Akt-Driven Bypass Signaling 2013 ·Cancer Research ·(unknown), Akihiko Kawahara, Kosuke Watari, Yûichi Murakami, Kahori Sonoda, (unknown), Hideaki Fujita, Masayoshi Kage, Hidetaka Uramoto, Carlota Costa, Michihiko Kuwano, Mayumi Ono	129
7	The predictive value of BRCA1 and RAP80 mRNA expression in advanced non-small-cell lung cancer patients treated with platinum-based chemotherapy 2013 ·Annals of Oncology ·Laura Bonanno, Carlota Costa, Margarita Majem, Adolfo Favaretto, Massimo Rugge, Rafael Rosell	14
8	BRCA1, LMO4, and CtIP mRNA Expression in Erlotinib-Treated Non–Small-Cell Lung Cancer Patients with EGFR Mutations 2013 ·Journal of Thoracic Oncology ·Niki Karachaliou, Carlota Costa, Ana Giménez‐Capitán, Miguel Ángel Molina‐Vila, Jordi Bertrán-Alamillo, Clara Mayo, Bartomeu Massutí, Margarita Majem, Enric Carcereny, Teresa Morán, José Javier Sánchez, Santiago Viteri, Amaya Gascó, Luciano Wannesson, John Souglakos, José Jimeno, Rafael Rosell	15
9	FAS and NF-κB signalling modulate dependence of lung cancers on mutant EGFR 2011 ·Nature ·Trever G. Bivona, Haley Hieronymus, Joel S. Parker, Kenneth Chang, Miquel Tarón, Rafael Rosell, Philicia Moonsamy, Kimberly B. Dahlman, Vincent A. Miller, Carlota Costa, Gregory J. Hannon, Charles L. Sawyers	315
10	Fifth Educational Symposium of the Spanish Lung Cancer Group: Report on the Molecular Biology Workshop 2011 ·Lung Cancer ·Isabel Bover, Christian Rolfo, Eloísa Jantus‐Lewintre, Rafael Sirera, Carlos Camps, Imane Chaib, (unknown), Susana Benlloch, Miguel Ángel Molina‐Vila, S. Simonetti, Carlota Costa, Ana Giménez‐Capitán, Pedro Méndez, Miguel Tarón, Rafael Rosell	0
11	mRNA expression levels and genetic status of genes involved in the EGFR and NF-κB pathways in metastatic non-small-cell lung cancer patients 2011 ·Journal of Translational Medicine ·Mariacarmela Santarpía, (unknown), María Sanchez-Ronco, Carlota Costa, Miguel Ángel Molina‐Vila, Ana Giménez‐Capitán, Jordi Bertrán-Alamillo, Clara Mayo, Susana Benlloch, Santiago Viteri, Amaya Gascó, (unknown), Enric Carcereny, Miquel Tarón, Rafael Rosell	22
12	mRNA Expression of BRCA1, PIAS1, and PIAS4 and Survival After Second-line Docetaxel in Advanced Gastric Cancer 2011 ·JNCI Journal of the National Cancer Institute ·Jia Wei, Carlota Costa, Yitao Ding, Zhengyun Zou, Lixia Yu, José Javier Sánchez, Xiaoping Qian, Hong Chen, Ana Giménez‐Capitán, Fanqing Meng, Teresa Morán, Susana Benlloch, Miquel Tarón, Rafael Rosell, Baorui Liu	46
13	Biomarkers in lung oncology 2010 ·Pulmonary Pharmacology & Therapeutics ·Rafael Rosell, A. Vergnenègre, Baorui Liu, Manuel Cobo, Bartomeu Massutí, Jia Wei, Miguel Ángel Molina‐Vila, Carlota Costa, Cristina Queralt, Miquel Tarón	14
14	The Prognostic Value of BRCA1 mRNA Expression Levels Following Neoadjuvant Chemotherapy in Breast Cancer 2010 ·PLoS ONE ·Mireia Margelí Vila, Beatriz Cirauqui, Eva Castellà, Gustavo Tapia, Carlota Costa, Ana Giménez‐Capitán, Agustí Barnadas, M. Sánchez Ronco, Susana Benlloch, Miquel Tarón, Rafael Rosell	33
15	A Sensitive Method for Detecting EGFR Mutations in Non-small Cell Lung Cancer Samples with Few Tumor Cells 2008 ·Journal of Thoracic Oncology ·Miguel Ángel Molina‐Vila, Jordi Bertran-Alamillo, Noemı́ Reguart, Miquel Tarón, Eva Castellà, Mariona Llatjós, Carlota Costa, Clara Mayo, (unknown), Cristina Queralt, Mónica Botia, (unknown), Esther Carrasco, (unknown), José Luís Mate, Teresa Morán, Rafael Rosell	83
16	A study of Ki-67, c-erbB2 and cyclin D-1 expression in CIN-I, CIN-III and squamous cell carcinoma of the cervix. 2007 ·PubMed ·Ramón Carreras, F. Alameda, Gemma Mancebo, (unknown), (unknown), Carlota Costa, Pere Fusté, Teresa Baró, S. Serrano	27
17	Study of chromosomal abnormalities in 11 cases of cervical dysplasia using comparative genomic hybridization on cotton-lint cervical samples 2005 ·Cancer Genetics and Cytogenetics ·Carlota Costa, Pere Fusté, Francesc Alameda, Marta Salido, Blanca Espinet, (unknown), Beatríz Bellosillo, Gemma Mancebo, Ramón Carreras, Sergi Serrano, Françesc Solé	2
18	Comparative genomic hybridization analysis of cutaneous large B‐cell lymphomas 2005 ·Experimental Dermatology ·(unknown), Carlota Costa, Blanca Espinet, Françesc Solé, Ramón M. Pujol, Eulàlia Puigdecanet, (unknown), (unknown), Fernando Gallardo, Teresa Estrach, (unknown), V. Romagosa, Sergi Serrano, Octavio Servitje	11
19	Lymphomatoid Papulosis Associated with Mycosis Fungoides: Clinicopathological and Molecular Studies of 12 Cases 2004 ·Acta Dermato Venereologica ·Fernando Gallardo, Carlota Costa, Beatríz Bellosillo, Françesc Solé, Teresa Estrach, Octavio Servitje, M. Pilar García-Muret, Carlos Barranco, Sergi Serrano, Ramón M. Pujol	29
20	Comparative Analysis of TCR-γ Gene Rearrangements by Genescan and Polyacrylamide Gel-electrophoresis in Cutaneous T-cell Lymphoma 2003 ·Acta Dermato Venereologica ·Carlota Costa, Fernando Gallardo, Ramón M. Pujol, Blanca Espinet, Beatríz Bellosillo, Teresa Estrach, Octavio Servitje, Carlos Barranco, Sergi Serrano, Françesc Solé	9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact